The complexities of biosimilars and the regulatory approval process.

In this report, various factors are addressed to improve the knowledge of biosimilars, including clinical, manufacturing, and cost considerations. PMID: 29957908 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29957908?dopt=Abstract

Source: The American Journal of Managed Care - June 1, 2018 Category: Health Management Authors: Lucio S Tags: Am J Manag Care Source Type: research

More News: Cancer & Oncology | Health Management | Healthcare Costs | Managed Care | Science